Daniel Parera

Investor, Entrepreneur, and Life Sciences Strategist

Professional Overview
Daniel Parera is an accomplished investor, entrepreneur, and strategic advisor with extensive experience in the life sciences and healthcare industries. As a Partner at Kurma Partners, he leverages his deep industry expertise and comprehensive network to identify and capitalize on emerging opportunities in the biopharmaceutical and medical technology sectors.

Experience Summary

Current Role
As a Partner at Kurma Partners, Daniel is responsible for leading the firm's investment activities, with a particular focus on innovative therapeutic and diagnostic solutions. In this role, he leverages his extensive experience in new product development, clinical strategy, and commercial planning to source and evaluate promising early-stage companies. His ability to provide strategic guidance and operational support has been instrumental in driving the success of Kurma's portfolio.

Career Progression
Prior to joining Kurma Partners, Daniel held a range of senior leadership positions within the life sciences industry. He co-founded IcanoMAB, a biotechnology company focused on the development of novel immunotherapies, where he served as CEO and Chief Medical Officer. Daniel also co-founded Prothea-X LLC, a healthcare consulting firm, and served as an Executive in Residence at both New Rhein Healthcare Investors and TVM Capital Group.

Earlier in his career, Daniel held various roles at Novartis, including Global Head of New Products & Portfolio Strategy for the Biopharmaceuticals division, Global Head of Development for Diagnostics, and Global Franchise Head of Strategic Marketing for Immunology and Infectious Diseases. He also gained valuable experience as an Engagement Manager at McKinsey & Company, where he advised clients on strategic and operational challenges in the healthcare sector.

Academic Background
Daniel holds a Doctor of Medicine (M.D.) degree from the University of Munich and a Master of Business Administration (MBA) from INSEAD.

Areas of Expertise

• Strategic and operational leadership in the life sciences and healthcare sectors

• New product development, clinical strategy, and commercial planning

• Venture capital and private equity investment in early-stage biotech and medtech companies

• Corporate strategy, business development, and M&A

• Expertise in immunology, infectious diseases, and diagnostics

Professional Impact
Throughout his career, Daniel has been recognized for his ability to drive innovation and deliver tangible results. His contributions have included leading the development and commercialization of several novel pharmaceutical and diagnostic products, as well as successful investment in and strategic guidance of high-potential life sciences startups.

Conclusion
With his extensive industry experience, deep technical expertise, and proven track record of success, Daniel Parera is a valuable asset to the Kurma Partners team and the broader life sciences ecosystem. His commitment to identifying and supporting transformative technologies positions him as a respected leader and trusted advisor in the field.